Lawrence Metelitsa is a Partner in the Capital Markets practice at Lucosky Brookman LLP, where he advises public companies, emerging growth issuers, and underwriters on a broad range of capital markets transactions and strategic corporate matters.
Lawrence focuses his practice on primary and secondary public offerings, registered direct offerings, PIPE transactions, at-the-market programs, shelf registrations, and mergers and acquisitions, with particular depth in the small- and mid-cap public company market. He is widely regarded as a go-to “deal lawyer” in this space, known for navigating complex transactional dynamics and structuring solutions that balance execution certainty with long-term capital markets strategy.
Clients value Lawrence’s practical, business-driven approach and his ability to anticipate issues before they arise, particularly for companies accessing the public markets for the first time or operating under heightened regulatory and market scrutiny. He is highly responsive, deeply engaged, and unafraid to immerse himself in a client’s business, often leveraging his extensive network of investors, bankers, and advisors to facilitate strategic introductions and accelerate outcomes.
In addition to his legal practice, Lawrence is actively involved in philanthropy. He serves on the National Board of Directors for Save a Child’s Heart, an international humanitarian organization that provides life-saving cardiac care to children from underserved regions. He is also a Director of the Lucosky Brookman Charitable Foundation, which focuses on supporting children’s charities and initiatives benefiting disadvantaged communities.
Prior to joining Lucosky Brookman, Lawrence practiced at a New York-based securities law firm, where he advised public companies and investment banks on registered and exempt securities offerings. He began his legal career clerking at a securities law firm while attending law school.
- New Jersey Law Journal 2025 Unsung Hero Award Winner
- New Jersey Law Journal 2025 Dealmakers Award Finalist
- New Leaders of the Bar Award 2018
- Super Lawyer Rising Star 2018
- Super Lawyer Rising Star 2017
- Advising issuers and underwriters in connection with U.S. and global offerings of securities and stock exchange listings.
- Representing issuers and their boards of directors with respect to reporting and other obligations under the U.S. securities laws and corporate governance and regulatory matters, specializing in the registration of securities under the Securities Act of 1933 and compliance with reporting requirements under the Exchange Act of 1934.
- Private investments in public equity financings (PIPEs)
- Mergers and Acquisitions
- Counseling public companies and Investment Banks on initial and secondary public offerings of securities
- Alternative public offerings and self-filings
- Secured and unsecured lending transactions
Mr. Metelitsa is also an active participant in various charitable organizations. He is a member of the New York Board of Young Leaders for the Save a Child’s Heart Foundation, an international humanitarian project that performs life-saving cardiac surgery for children from developing countries. In addition, Mr. Metelitsa is also a director of the Lucosky Brookman Charitable Foundation with the primary goal of using the power of philanthropy to impact the lives of those less fortunate with a particular focus on children’s charities.
Prior to joining Lucosky Brookman, Mr. Metelitsa was an associate at a New York-based securities law firm after having clerked for more than two years while attending law school.
Mr. Metelitsa is a graduate of New York Law School where he earned the 2007 and 2008 Grand Street Boys Association Scholarship for academic excellence. Mr. Metelitsa graduated from Binghamton University, cum laude, with a Bachelor of Arts Degree in Politics, Philosophy and Law. While attending college, he interned at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- NASDAQ-listed Quantum computing technology company in a series of registered offerings and private placements over 9 months representing over $1.4 Billion Dollars in sold securities.
- NASDAQ-listed SaaS company in groundbreaking investment agreement with JPE and minority co-investors injecting $1 Billion in cash creating a new acquisition platform.
- New York based Investment Bank in $270 Million Dollar private placement transaction in connection with a “World Coin” Digital Asset Treasury Strategy including “World Coin”
- New York based Investment Bank in $100 Million Dollar private placement transaction in connection with a “Light Coin” Digital Asset Treasury Strategy
- New York based global logistics and freight forwarding company, in connection with a $90 Million sale to largest logistics company in the UAE.
- NASDAQ- representation of New York based investment bank in connection with $200 Million Dollar SPAC
- New York based global logistics and freight forwarding company, in connection with the acquisition of 11 international subsidiaries and $35 Million Dollar secured revolving credit facility
- New York based investment bank in connection $50 Million Dollar private placement into Australian based foreign private issuer.
- NASDAQ-listed national provider of transformational business technology solutions and services, in connection with the $11.5 Million sale of one of its technology divisions, including all related intellectual property
- NASDAQ – listed issuer in connection with two concurrent private placement offerings totaling $200 Million Dollars in connection with “Solana” Digital Asset Treasury Strategy
- Uplist of building products company to NASDAQ and simultaneous $6 Million registered offering
- Illinois-based sports engineering and construction company in a $7.5 Million private placement and simultaneous alternative public offering consisting of common stock and warrants.
- New Jersey-based specialty food manufacturer and retailer in a $12.5 Million private placement and simultaneous alternative public offering (including 2 follow-on offerings consisting of common stock and warrants).
- Australian based ASX listed digital health company in a $12 Million Dollar underwritten offering of its ADS’s and dual-listing onto the NASDAQ
- New Jersey-based AIM-listed diagnostics company specializing in the development, manufacture, and supply of rapid, point-of-care screening and testing products in a $17.5 Million underwritten offering of its common stock and dual-listing onto the NASDAQ Global Select Market.
Featured Transactions
$750 Million
Quantum Computing Inc. (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, announced that it has entered into...
read more
$1 Billion
Lucosky Brookman’s long-time client SilverSun Technologies, Inc. (Nasdaq:SSNT) and Jacobs Private Equity II, LLC (JPE) have announced a...
read more